Skip to content

Post-failure Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Cow's Milk Allergy Observational Cohort Study

Post-failure Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Cow's Milk Allergy Observational Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07448740
Acronym
Post-TEHITI
Enrollment
30
Registered
2026-03-04
Start date
2025-03-31
Completion date
2030-10-24
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cow's Milk Protein Allergy

Brief summary

Subjects who failed to become tolerant within 12 months after randomization within one of the three arms in the TEHITI study, can participate in the post-TEHITI observational trial to study the natural tolerance induction process.

Detailed description

In this observational study the investigators will study the time to complete tolerance in cow's milk allergic children who tolerate 20' heated milk but failed the OFC with unheated milk 12 months after passing the 20' boiled cow's milk OFC. Moreoever, the investigators want to document all clinical reactions and potential cofactors during the tolerance induction process. The investigators anticipate that the whole cohort will become tolerant in a time span shorter than 48 months. Therefore the study period in each participant will be 48 months or the period to achieve complete tolerance (which comes first).

Interventions

None listed

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER
Jessa Hospital
CollaboratorOTHER
Imelda Hospital, Bonheiden
CollaboratorOTHER
Algemeen Ziekenhuis Maria Middelares
CollaboratorOTHER
AZ Sint-Jan AV
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years

Inclusion criteria

Participants eligible for inclusion in this study must meet all of the following criteria: * participation in s68299 * failure to challenge test with unheated cow's milk * passed challenge test with unheated cow's milk but with symptoms developing between challenge and termination visit related to cow's milk intake at home

Exclusion criteria

Participants eligible for this study must not meet any of the following criteria: * Subjects not priorly enrolled in s68299 * Subjects enrolled in s68299 who passed the challenge test and have no complaints upon regular cow's milk consumption at termination visit * Subjects who refuse to consent/assent with the study

Design outcomes

Primary

MeasureTime frameDescription
Number of participants that acquire tolerance for cow's milk after initially failing a cow's milk provocation test48 monthsThe number of participants that spontaneously acquire tolerance for cow's milk after initially failing a cow's milk provocation test will be counted.

Secondary

MeasureTime frameDescription
Adverse clinical reactions to cow's milk protein intake during observational period48 monthsNature and condition of clinical reactions in relation to different heated and/or unheated forms of cow's milk protein intake during observational period

Countries

Belgium

Contacts

CONTACTDominique MA Bullens, Prof, MD
dominique.bullens@uzleuven.be+32016343801
CONTACTMarleen Jannis
marleen.jannis@uzleuven.be+32016343801
PRINCIPAL_INVESTIGATORJasmine Leus, MD

Maria Middelares Hospital, Gent

PRINCIPAL_INVESTIGATORKatrien Coppens, MD

Imelda Hospital, Bonheiden

PRINCIPAL_INVESTIGATORSophie Verelst, MD

Jessa Hospital, Hasselt and KU Leuven

PRINCIPAL_INVESTIGATORKate Sauer, MD

AZ Sint-Jan AV

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026